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A B S T R A C T
A comprehensive monitoring of a broad set of antibiotics in the final effluent of wastewater treatment plants
(WWTPs) of 7 European countries (Portugal, Spain, Ireland, Cyprus, Germany, Finland, and Norway) was carried
out in two consecutive years (2015 and 2016). This is the first study of this kind performed at an international
level. Within the 53 antibiotics monitored 17 were detected at least once in the final effluent of the WWTPs, i.e.:
ciprofloxacin, ofloxacin, enrofloxacin, orbifloxacin, azithromycin, clarithromycin, sulfapyridine, sulfamethox-
azole, trimethoprim, nalidixic acid, pipemidic acid, oxolinic acid, cefalexin, clindamycin, metronidazole, am-
picillin, and tetracycline. The countries exhibiting the highest effluent average concentrations of antibiotics were
Ireland and the southern countries Portugal and Spain, whereas the northern countries (Norway, Finland and
Germany) and Cyprus exhibited lower total concentration. The antibiotic occurrence data in the final effluents
were used for the assessment of their impact on the aquatic environment. Both, environmental predicted no
effect concentration (PNEC-ENVs) and the PNECs based on minimal inhibitory concentrations (PNEC-MICs) were
considered for the evaluation of the impact on microbial communities in aquatic systems and on the evolution of
antibiotic resistance, respectively. Based on this analysis, three compounds, ciprofloxacin, azithromycin and
cefalexin are proposed as markers of antibiotic pollution, as they could occasionally pose a risk to the en-
vironment. Integrated studies like this are crucial to map the impact of antibiotic pollution and to provide the
basis for designing water quality and environmental risk in regular water monitoring programs.
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Antibiotics are a class of pharmaceutical active compounds with
high usage and consumption worldwide. By definition, an antibiotic is a
chemotherapeutic agent that specifically inhibits, by cell destruction or
growth inhibition, the proliferation of bacteria (Kümmerer, 2009).
According to Kümmerer (2009) over 250 different chemical substances
are registered as antibiotics for human and/or animal health use
globally. Based on the analysis of data from scientific literature and
national and regional surveillance systems from 71 countries over the
past 10 years, antibiotic use is growing steadily worldwide (30%),
driven mainly by rising demand in low- and middle-income countries
(Gelband et al. 2015). This increase in the use of antibiotics and the
awareness about their side effects have led to increasing concern re-
garding their potentially detrimental effects in the environment. In
particular, it is suspected that their occurrence can accelerate resistance
spread in the environment (Bengtsson-Palme et al., 2018), with po-
tential implications on human health. According to the World Health
Organization (WHO), antimicrobial resistance is a major challenge to
global human and animal health, food safety, and development today,
with the perspective of aggravation in the upcoming years, if effective
measures are not implemented (World Health Organization, 2014).
Because of the intensive use of antibiotics for human, veterinary and
agriculture purposes, these compounds are continuously released into
the environment from anthropogenic sources. In urban areas, waste-
water treatment plants (WWTPs), when available, are among the main
receptors of antibiotics, part of which persist after the treatment and
can be released into various environmental compartments (Michael
et al., 2013). Several studies about the presence of antibiotics in
WWTPs have been conducted in the last couple of decades. Most of
them have focused on a limited amount of compounds (between 2 and
33 target antibiotics). Further, studies comparing the situation in dif-
ferent countries are nearly absent and, in the case that a single country
as China, Croatia, Sweden, Portugal, United Kingdom, and Greece is
analysed, a limited number of WWTPs, varying between 2 and 19
within each country has been studied (Gao et al., 2012; Johnson et al.,
2017; Kosma et al., 2014; Lindberg et al., 2005; Pereira et al., 2015;
Senta et al., 2013; Wang et al., 2018; Zhang et al., 2019). Among the
most comprehensive studies so far are those by Gracia-Lor et al. (2011),
who monitored 26 antibiotics among other pollutants in 19 WWTPs in
Spain and Birošová et al. (2014), who monitored up to 33 antibiotics in
2 WWTPs in Slovakia. This type of monitoring studies permits the
evaluation of temporal and geographical trends in antibiotic occur-
rence. However, given the lack of standardized methodologies and
other technical biases, data reported in distinct studies are poorly
comparable. In this situation, transnational efforts constitute an es-
sential contribution for the establishment of environmental protection
guidelines that can be globally applied. To the authors’ knowledge such
international monitoring studies of antibiotics in WWTPs are not
available, which is a major gap for implementing mitigation regula-
tions/procedures. Global monitoring programs would represent an
important step forward on water protection worldwide, as they would
contribute to compare country-specific scenarios, to provide the basis
for international action and also would allow assessing the progress
achieved concerning any potential environmental protection action. In
fact, the results of environmental monitoring are of fundamental im-
portance to environmental management in general, as the drafting and
prioritization of environmental policies is based on the findings of en-
vironmental monitoring (Helmer, 1994). The monitoring of antibiotic
contamination is particularly relevant given its association with anti-
biotic resistance, known to be highly heterogeneous at a global scale
(Hendriksen et al., 2019; Pärnänen et al., 2019).
The current study was hence motivated by the need for water
monitoring at an international level to acquire reliable and comparable
analytical data concerning antibiotics occurrence. With this aim, the
final effluent of 13 WWTPs located in 7 European countries (Portugal,
Spain, Ireland, Cyprus, Germany, Finland, and Norway) was sampled
twice (early Spring and early Autumn) in two consecutive years (2015
and 2016) and was monitored for 53 antibiotic residues belonging to 10
different therapeutic classes. The countries were selected following a
north-to-south gradient in the use of antibiotics as well as in the pre-
valence of antibiotic resistance in clinical settings as reported in the
2017 EARS-Net surveillance report (ECDC European Centre for Disease
Prevention and Control, 2017). The specific objectives of the study
were: (i) to provide an overview of the presence and concentration of
antibiotics in final effluents of WWTPs located in different European
countries; (ii) to assess geographical and temporal trends about the
occurrence of these contaminants; (iii) to infer about the potential en-
vironmental and human health risk posed by antibiotic residues in final
treated wastewater effluents; and (iv) to propose robust analytical tools
and indicator compounds to be used in regular water-monitoring pro-
grams, hence making feasible the comparison of country-based studies.
2. Materials and methods
2.1. Sampling campaigns
Four sampling campaigns were carried out in early Spring (March
2015 and 2016) and early Autumn (October 2015 and September
2016), suggested to correspond to the highest and the lowest peaks of
antibiotic consumption, respectively (Caucci et al., 2016; Sun et al.,
2012). In each of the 4 sampling campaigns, 24-h composite samples
were collected in 3 consecutive days (Tuesday, Wednesday, and
Thursday) at the outlet of 13 urban WWTPs belonging to 7 European
countries (Portugal, Spain, Cyprus, Ireland, Germany, Finland, and
Norway) (Fig. 1, Table S1). Two WWTPs were monitored in each
country except in Spain and Norway, where a single WWTP was sam-
pled. In Portugal, due to a problem in the WWTP PT1 in the sampling
campaign of March 2016, a third WWTP (PT3), located in the same
region, was sampled instead. General characteristics of the selected
WWTPs are gathered in Table S2. For every campaign, data concerning
weather conditions were collected for the 3 days of sampling and the
day before (Table S3).
All participants collected the samples on the same dates and
adopted a common protocol for sampling and sample processing (Gros
et al., 2013). Amber glass bottles pre-rinsed with ultrapure water were
used to collect ca. 200–250 mL wastewater from each of the WWTPs,












Fig. 1. Map of the 13 European wastewater treatment plants (WWTPs) from
where effluent wastewater was sampled. Portugal (PT), Spain (ES), Cyprus
(CYP), Ireland (IL), Germany (DE), Finland (FI), Norway (NO).
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treatment.
2.2. Reagents and chemicals
Fifty-three antibiotics, distributed in 10 classes, were monitored:
fluoroquinolones (n = 8), quinolones (n = 4), penicillins (n = 5),
cephalosporins (n = 6), macrolides (n = 6), tetracyclines (n = 4),
lincosamides (n = 2), sulfonamides (n = 15), a dihydrofolate reductase
inhibitor (n = 1), and nitroimidazole antibiotics (n = 2) (Table S4). All
antibiotic standards were of high purity grade (> 90%) and purchased
from Sigma–Aldrich: tetracycline, chlortetracycline, oxytetracycline,
and lincomycin were purchased as hydrochloride salts; oxacillin, cefa-
zolin, cefotaxime, and cefapirin were acquired as sodium salts; peni-
cillin V and penicillin G as potassium salts; amoxicillin and ampicillin
were purchased as trihydrate salts; tylosin and doxycycline were ac-
quired as tartrate and hyclate salts, respectively. Isotopically labelled
compounds, used as internal standards, were: ofloxacin-d3, cipro-
floxacin-d8 (as hydrochloride hydrate salt), erythromycin-N,N-di-
methyl 13C, ampicillin-15N, and ronidazole-d3, purchased from Sig-
ma–Aldrich, and azithromycin-d3, sulfamethoxazole-d4, and
lincomycin-d3, from Toronto Research Chemicals (Ontario, Canada).
Sulfadimethoxine-d6 and sulfadoxine-d3, used as surrogate standards,
were purchased from Sigma–Aldrich.
Individual stock standard solutions, as well as isotopically labelled
internal standard and surrogate standard solutions, were prepared at a
concentration of 1000 mg/L. After preparation, the solutions were
stored at −20 °C (Gros et al., 2013). Standard solutions containing the
antibiotic mixtures were prepared in methanol/water (50:50, v/v) just
before the analysis; by mixing appropriate amounts of the intermediate
standard solutions. Separate mixtures of isotopically labelled internal
standards were prepared in methanol, except ampicillin-15N, which was
diluted in acetonitrile/water (50:50, v/v). Further diluted solutions
were prepared in a methanol/HPLC water mixture (50:50, v/v).
Glass fibre filters (1 µm) and PVDF filters (0.45 µm) from Whatman
(UK) were used for filtration of the samples. OASIS Hydrophilic-
Lipophilic-Balanced (HLB) cartridges (60 mg, 3 mL) from Waters
Corporation (Milford, MA, U.S.A.) were used for solid phase extraction.
HPLC grade methanol, acetonitrile, formic acid 98% and water
(LiChrosolv) were purchased by Merck (Darmstadt, Germany).
Ammonium hydroxide, hydrochloric acid 37% and the nitrogen for
drying were purchased by Abelló Linde S.A. (Valencia, Spain).
2.3. Analytical procedure
2.3.1. Sample pre-treatment
Each sampling day, water was filtered by 1 μm glass fibre filter
followed by 0.45 μm PVDF filter. An appropriate volume of 0.1 M
Na2EDTA solution was added to the filtered water to get a final con-
centration of 0.1% (g solute/g solution), and the pH adjusted to 2.5
with hydrochloric acid 0.1 M. Samples were further processed: 50 µL of
surrogates mix was added to each of the 50 mL samples. Solid phase
extraction (SPE) was performed according to Gros et al. (2013). Briefly,
Oasis HLB (60 mg, 3 mL) cartridges were first conditioned with
2 × 3 mL methanol followed by 2 × 3 mL water (HPLC grade, and pH
adjusted to 2.5 with HCl 0.1 M). Then 50 mL of filtered effluent were
loaded onto the SPE cartridge samples at approximately 1 mL/min,
approximately, under vacuum conditions. Each cartridge was cleaned
with 2 × 3 mL HPLC water (under gravity conditions) and dried under
vacuum conditions for 10–15 min. The cartridges were protected with
parafilm and preserved at −20 °C before shipment with dry ice to the
reference analytical laboratory, where the samples were stored at
−20 °C until analysis (< 2 weeks). For analyses, the samples were
eluted from the cartridge with 6 mL of ultra-pure methanol, evaporated
under N2 stream near dryness, and reconstituted with 1 mL of mixture
of methanol and water (50:50, v/v). Finally, 10 µL of a standard 1 ng/
mL mixture containing all isotopically labelled standards was added to
the extract as internal standards. For an accurate quantification, con-
centrations were calculated by internal calibration using the isotope-
labelled standards. Recovery values of the extraction method were
calculated in each occasion (each sampling campaign) and used to
correct the quantification values obtained using these calibration
curves. To determine the recoveries, wastewater effluent was spiked in
triplicate with a standard mixture containing all antibiotics at a final
concentration of 10 ng/L. Recoveries were determined by comparing
the initial concentrations after spiking with the concentrations obtained
after the whole SPE procedure. Method detection limits (MDL) and
method quantification limits (MQL) were also determined in each
sampling campaign and for each antibiotic as the minimum detectable
amount of compound with a signal-to-noise of 3 and 10, respectively.
The analytical quality parameters MDL, MQL and recovery values (%)
can be found in Table S4. The MDL achieved ranged from 5.31 ng/L up
to 19.21 ng/L, whereas MQLs ranged from 17.72 to 46.91 ng/L. Con-
cerning the extraction methodology, recoveries achieved for all target
compounds ranged between 60 and 120%.
2.3.2. Chemical analysis
The chemical analysis was carried out with an ultra-performance
liquid chromatography system (UPLC) using an Acquity HSS T3 column
(50 mm × 2.1 mm i.d., 1.7 μm particle size), both from Waters
Corporation (Mildford, MA, USA). The volume of sample injected was
5 µL. The UPLC system was coupled to a mass spectrometer hybrid
quadrupole-ion trap (UPLC-5500 QTRAP, Applied Biosystems, Foster
City, CA, USA) equipped with a Turbo V electrospray ionization source
working in positive ionization mode. Two multiple reaction monitoring
(MRM) transitions per compound were recorded by using the Scheduled
MRM™ algorithm (see Gros et al., 2013 for details). All data were ac-
quired and processed using Analyst 1.6.3 software.
2.4. Environmental risk assessment (ERA)
The environmental risk associated with antibiotic residues released
with the WWTP effluents was assessed using risk quotient (RQ). Risk
quotients are indices based on empirical data for quantification of the
environmental risk of chemicals and involve the comparison of the
environmental concentrations of pollutants with the concentrations at
which adverse effects on target organisms are expected (Isidori et al.,
2005). Risk quotients were calculated according to the European
Community guidelines (EC TGD, 2003), using Eq. (1):
=RQ PEC PNEC( )/( ) (1)
where PEC is the “Predicted Environmental Concentration” for each
antibiotic and PNEC is its “Predicted No Effect Concentration”. Calcu-
lations of PEC were based on the antibiotic levels detected in WWTP
effluent of the 13 WWTPs considered in this work (Table 1 for average
values and Table S5 for complete raw data). In the present study, it was
assumed that the final effluents of the WWTPs are discharged in
freshwater ecosystems so that the impact of the antibiotic presence in
wastewater in the different scenarios in the 7 countries can be com-
pared. Therefore, PEC was calculated by applying a dilution factor (the
ratio between the volume of freshwater available and the domestic
sewage discharge) to the corresponding occurrence values following the
approach by Keller et al. (2014) using Eq. (2):
=PEC MC DF( )/( ) (2)
where MC is the “Measured Concentration” in the wastewater effluents
for each antibiotic and WWTP and DF is the “National annual median
dilution factor” calculated for each country by Keller et al. (2014). The
paper reports the calculated DF for domestic effluents for approxi-
mately 100 countries. These DF values were used by the same authors
as surrogates to compare risk levels caused by chemical exposure be-
tween countries. The DF for the 7 countries of our study were extracted
from this report and can be found in Table S6.
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Two PNEC values were considered following the approach by Tell
et al. (2019): environmental PNECs (PNEC-ENVs) and the PNECs based
on minimum inhibitory concentrations (PNEC-MICs). PNEC-ENVs were
calculated based on the environmental toxicity data collected from in-
dustrial and literature sources by Tell et al. (2019). Preference was
given to data generated following the OECD (Organization for Eco-
nomic Cooperation and Development) guidelines and from cyano-
bacteria, as they are considered more sensitive to antibiotics than other
organisms (Le Page et al., 2017). PNEC-MICs values were developed by
Bengtsson-Palme and Larsson (2016) based on MIC data from the EU-
CAST (European Committee on Antimicrobial Susceptibility Testing
database). As recommended by Tell et al. (2019), the lowest of the two
PNEC values was used for the environmental risk assessment in this
work in order to be protective with ecological resources, and also to
lower the pressure for the evolution, selection and maintenance of
antimicrobial resistance in the environment. PNEC-ENV and PNEC-MIC
extracted from the communication by Tell et al. (2019) for those anti-
biotics detected in our study can be found in Table S7.
2.5. Statistical analysis and data treatment
The variations between sampling campaigns for the same WWTP
and between different WWTPs were analysed in order to obtain the
temporal and geographical variations, respectively. The mean values
comparison was performed using the analysis of variance (ANOVA)
with the post hoc Tuckey’s test (p < 0.05) using the IBM SPSS
Statistics v26. To perform the data analysis, and avoid missing values,
the results below the method quantification limits (MQL) were assumed
as half of the value of the MQL of the respective sampling campaign
(see Table S5), and in the case of results below method detection limit
(MDL) it was used the value of zero.
Annual human consumption of antibacterials for systemic use (ATC
group J01) in the community (primary care sector) as defined daily
dose (DDD) per 1000 inhabitants was extracted from the European
Surveillance of Antimicrobial Consumption Network (ESAC-Net) for
years 2015 and 2016 for each of the 7 countries (Fig. 4).
3. Results and discussion
3.1. Occurrence of antibiotic residues in treated wastewaters in different
European countries
Fifty-three antibiotics belonging to 10 different chemical classes
were monitored in the final effluents collected in wastewater treatment
plants located in different European countries. Targeted antibiotics
were selected based on their human and veterinary usage worldwide, as
well as their occurrence and ubiquity in the aquatic environment (Gros
et al., 2013; ECDC EFSA EMA, 2017. Among the 53 antibiotic com-
pounds analysed in wastewater effluents (Table S4), 17 were detected
in at least one of the 13 urban WWTPs studied, located in the 7 different
countries (Table 1). The concentration of these 17 antibiotics (cipro-
floxacin, ofloxacin, enrofloxacin, orbifloxacin, azithromycin, clari-
thromycin, sulfapyridine, sulfamethoxazole, trimethoprim, nalidixic
acid, pipemidic acid, oxolinic acid, cefalexin, clindamycin, me-
tronidazole, ampicillin, and tetracycline) in the studied WWTP are
shown in Table S5 and represented in Fig. S1. The highest antibiotic
concentrations observed were for fluoroquinolones: up to 1435.5 ng/L
of ciprofloxacin in Portugal, and 613.0 ng/L of ofloxacin in Cyprus
(Table S5). Of the four fluoroquinolones detected, two (enrofloxacin
and orbifloxacin) are used in veterinary medicine (Table S4) and were
only occasionally detected in samples from Spain and Cyprus, respec-
tively (Fig. S1). The macrolides azithromycin and clarithromycin were
observed in all countries presenting their maximal concentrations of
1577.3 ng/L and 346.8 ng/L, respectively in WWTP effluents from
Portugal. In the case of azithromycin, the concentrations observed in
the Portuguese WWTP PT2 samples were significantly higher
(p < 0.05) than those observed in the WWTP effluent samples from
Cyprus, Finland and Norway (Fig. S1). Of the 15 sulfonamide anti-
biotics screened, only sulfapyridine and sulfamethoxazole were de-
tected in the final effluents, with maximal values of 583.6 ng/L in
Norway and 220.9 ng/L in Cyprus, respectively. Considering average
values, the Spanish WWTP effluent samples presented significantly
higher (p < 0.05) concentrations of sulfamethoxazole than most of the
other samples (Fig. S1). The dihydrofolate reductase inhibitor tri-
methoprim was detected in all the WWTPs, in almost all the sampling
campaigns. Trimethoprim is commonly used in combination with sul-
famethoxazole, as cotrimoxazole (Batt et al., 2006). However, the ratio
between the concentrations of these two compounds was not consistent
with the ratio used in clinical treatment (1:5; trimethoprim:sulfa-
methoxazole) for any of the samples from the different countries. The
concentration of SMX in influent wastewater has been reported as four
times higher than that of trimethoprim in several studies (Perez et al.,
2005; Jelic et al., 2015). However, trimethoprim biodegradation in CAS
commonly is not as efficient as that for SMX (Perez et al., 2005;
Verlicchi et al., 2012) and therefore trimethoprim concentration was
even higher than that for SMX in most of the final effluents monitored
in this study (Table 1). Three of the quinolone antibiotics measured (i.e.
nalidixic acid, oxolinic acid, and pipemidic acid) were detected in at
least one sample. The levels of pipemidic acid presented no significant
variation among WWTP effluent samples. The highest concentration
was observed in Portugal (117.6 ng/L) in WWTP PT1, although this
compound was detected just in the first sampling campaign. Nalidixic
acid and oxolinic acid were only detected in some of the sampling
campaigns in Ireland, in samples from both WWTPs in the case of na-
lidixic acid or just in WWTP IL2 samples for oxolinic acid. In addition,
ampicillin was also only quantified in the Irish samples collected in
Spring (although detected below the limit of quantification in Autumn
2015), with the maximum concentration observed being 231.1 ng/L
(Fig. S1). Other antibiotics presented maximum concentrations in dif-
ferent countries – cefalexin in Finland (1047.8 ng/L), clindamycin in
Spain (194.5 ng/L), metronidazole in Ireland (230.0 ng/L), and tetra-
cycline in Portugal (613.6 ng/L) (Table S5) indicating the need of
studying several antibiotics to get a clear picture of antibiotic pollution.
The concentration values measured in our study (ranging between ng to
µg/L) are in agreement with those found in final effluents of other
European WWTP, as reported by other authors (Johnson et al., 2017;
Lindberg et al., 2005; Senta et al., 2013; Gracia-Lor et al., 2011;
Birošová et al., 2014) and in particular by Carvalho and Santos in their
review on the occurrence of antibiotics in wastewater and different
environmental matrices (Carvalho and Santos 2016) and, most recently,
in the report by the European Commission Joint Research Center (JRC)
(Sanseverino et al., 2018) where concentrations in WWTP effluents for
the majority of antibiotics were between 0.1 and 1 µg/L. Nevertheless,
some differences were identified among the examined samples in the
present study. The countries exhibiting the highest average effluent
concentrations were Ireland and the southern countries Portugal and
Spain. In contrast, Cyprus, where tertiary treatment or membrane
bioreactors are used, and northern countries exhibited lower total
concentrations of antibiotics (Fig. 3).
Temporal variations of antibiotic concentrations (grouped based on
their antibiotic class) were evaluated based on the comparison of data
collected in two different seasons (early Spring and early Autumn) and
in two consecutive years. The comparison of the two years of sampling
(2015 vs 2016) revealed significant differences in the cumulative values
of antibiotics concentration only in Cyprus, with significantly
(p = 0.006) higher concentrations in 2016 (Fig. S2(a) and (c)). When
evaluating the antibiotic presence by season, significant variation in
cumulative antibiotic concentrations was only observed for some
countries (Fig. 2): Antibiotic concentrations in early Spring (March
2015 and 2016) were significantly higher than those in early Autumn
(September 2015 and October 2016) in samples from Spain, Ireland and
Finland WWTPs (Fig. 2). These findings are in line with the seasonality
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of antibiotic prescriptions reported in other publications (Caucci et al.,
2016; Sun et al., 2012). However, the inverse was observed in one of
the Cyprus WWTPs (CYP1), with higher concentrations of antibiotics in
early autumn than in early spring, whereas no clear seasonal trend was
observed for Portugal, Germany or Norway. The analysis of each anti-
biotic class did not show clear seasonal patterns. For instance, macro-
lides, one of the antibiotic classes detected at the highest concentrations
in effluent samples in this study, did not exhibit significant differences
in the sampling campaigns. On the contrary, they did display high
seasonality in their consumption in some countries such as Switzerland,
with a high peak in winter as reported in other studies (Coutu et al.,
2013). Macrolides are usually prescribed to treat respiratory tract in-
fections in patients living in the community, and in the case of clari-
thromycin specifically to treat lung infections (Tanaka et al., 2002).
However, significant variation between Spring and Autumn was ob-
served for certain antibiotics in certain effluents collected from the
same WWTP: cefalexin (CYP1, IL1 and IL2), ofloxacin (FI1), cipro-
floxacin (FI2), enrofloxacin (ES1), pipemidic acid (ES1 and IL1), and
ampicillin (IL1) (Fig. S1). In summary, there are antibiotic- and
country-specific trends in the concentration of antibiotics found in
wastewater effluents. These findings did not corroborate the hypothesis
that higher concentration should be detected overall in early Spring
(end of winter) than in early Autumn (or late Summer). The quantifi-
cation of antibiotics concentration in wastewater before the treatment
would probably better reflect the antibiotics consumption. The treat-
ment processes reduce antibiotic levels to different extents depending
not only on the type of treatment applied in each case (Table S2), but
also on other conditions, including physical-chemical properties of the
pollutant, climate variations as for example the temperature, which
influences the efficiency of the biological processes as better removal is
obtained at temperatures of 15–20 °C compared to below 10 °C
(Krzeminski et al., 2019; Ramin et al., 2018; Vieno et al., 2005). In
conclusion, a higher sampling frequency (at least monthly) and the
analysis of the raw influent is recommended to bring further insight
about the relationship between antibiotic consumption versus waste-
water antibiotic occurrence.
3.2. Human antibiotic consumption and antibiotic occurrence in wastewater
effluents
Consumption of antibiotics varies among countries and it could be
hypothesized that these differences are still noticeable in treated was-
tewater effluents. To test this hypothesis, annual human consumption
of antibacterials for systemic use (see Section 2.5) was compared with
actual concentrations found in wastewater effluents for each of the 7
countries in the two years monitoring study (Fig. 4). Based on the ECDC
reports, Cyprus was the country with the highest consumption of an-
tibiotics followed by Ireland, Spain, Portugal, Finland, Norway, and
Germany (Fig. 4b). As described in the previous section, Ireland, Spain
and Portugal were the countries exhibiting the highest total antibiotic
concentrations whereas Norway, Finland, and Germany showed lower
concentrations (Fig. 4a). Therefore, higher antibiotic consumption rates
were, in general, in agreement with higher total antibiotic concentra-
tions in the WWTP effluent samples for Ireland, Portugal, and Spain. In
contrast, lower antibiotic consumption rates correlated with lower total
antibiotic concentrations in the WWTP effluent samples from Finland,
Norway, and Germany. Curiously, Cyprus, with the highest antibiotic
consumption rates, exhibited one of the lowest total concentrations in
final effluent samples (Fig. S2). This may be due to either an over-
estimation of Cyprus antibiotic consumption, since it was the only
country for which ESAC-net data on consumption was also including
hospital sector, or/and to the advanced wastewater treatment used in
the Cyprus WWTPs analysed; i.e. sand filtration + chlorination as ad-
ditional tertiary treatment to CAS (CYP1) and MBR treatment with ul-
trafiltration membrane (CYP2) (Table S2). The search for potential
correlations between antibiotic consumption and its occurrence in final
effluent is influenced by different factors, in particular antibiotic me-
tabolism in the human body, the chemical and biological stability of the
antibiotics during wastewater treatment and the specific wastewater
treatment process and operational conditions of each WWTP (Jelic
et al., 2015; Michael et al., 2013). Therefore, if community-based epi-
demiological studies or health and/or well-being assessments based on
wastewater are the aims, the analysis of raw (influent) wastewater is
preferred (Gracia-Lor et al., 2017). In contrast, the measurement of the
range and concentration of antibiotics in final effluent permits the as-
sessment of the impact of antibiotics use in the environment, when
sanitation systems that comply with legislative recommendations are
implemented. This was the aim of the present study.
Table 1
Occurrence values (ng/L) for the 17 antibiotics detected in the samples from the 13 WWTPs considered in this study: Portugal (PT), Spain (ES), Cyprus (CYP), Ireland
(IL), Germany (DE), Finland (FI), and Norway (NO). Concentrations (ng/L) are calculated as the average from the 4 sampling campaigns or 3 sampling campaigns in
the case of PT1 and 1 sampling campaign in the case of PT3. Occurrence values for each day and sampling campaign can be found in Table S5.
Chemical group Antibiotic PT1 PT2 PT3 ES1 CYP1 CYP2 IL1 IL2 DE1 DE2 FI1 FI2 NO1
Cephalosporins Cefalexin 38.4 37.0 <MDL 65.2 66.3 65.0 66.4 87.6 <MDL <MDL 203.3 308.0 60.7
Dihydrofolate reductase
inhibitors
Trimethoprim 69.1 146.3 190.6 102.8 74.2 44.0 141.3 121.0 15.2 105.0 182.0 186.7 119.7
Fluoroquinolones Ciprofloxacin 457.3 584.9 231.4 200.3 316.8 252.3 259.8 234.0 43.8 230.6 38.4 43.2 159.2
Enrofloxacin <MDL <MDL <MDL 69.4 <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL
Ofloxacin 89.7 184.9 132.8 142.3 305.1 196.7 65.4 39.9 <MDL 66.5 20.0 22.8 27.1
Orbifloxacin <MDL <MDL <MDL <MDL 6.7 6.5 <MDL <MDL <MDL <MDL <MDL <MDL <MDL
Lincosamides Clindamycin 8.5 86.6 31.5 101.4 6.5 27.8 42.5 59.1 <MDL 110.7 88.8 94.2 97.1
Macrolides Azithromycin 361.8 597.5 178.9 299.5 48.0 45.2 266.7 260.8 126.2 290.4 129.3 130.7 149.7
Clarithromycin 74.2 118.7 313.2 112.0 <MDL 11.9 204.4 189.4 76.5 123.4 4.5 4.8 20.8
Nitroimidazole
antibiotics
Metronidazole <MDL <MDL <MDL 76.1 19.6 <MDL 88.6 78.2 7.6 20.3 20.1 41.9 93.2
Penicillins Ampicillin <MDL <MDL <MDL <MDL <MDL <MDL 99.4 68.1 <MDL <MDL <MDL <MDL <MDL
Quinolones Nalidixic Acid <MDL <MDL <MDL <MDL <MDL <MDL 50.3 25.3 <MDL <MDL <MDL <MDL <MDL
Oxolinic Acid <MDL <MDL <MDL <MDL <MDL <MDL <MDL 5.3 <MDL <MDL <MDL <MDL <MDL
Pipemidic Acid 15.0 10.8 20.1 30.1 10.1 15.2 18.2 4.4 11.8 <MDL 4.8 3.2 7.5
Sulfonamides Sulfamethoxazole 30.2 7.1 <MDL 123.4 13.3 68.5 53.0 44.0 22.9 34.9 <MDL <MDL 48.6
Sulfapyridine 84.5 4.7 48.8 63.9 8.7 48.7 95.5 93.6 22.7 112.0 89.2 98.8 184.0
Tetracyclines Tetracycline 231.2 165.7 147.5 <MDL 36.9 24.5 141.0 194.2 <MDL 15.4 70.6 16.8 179.2
<MDL Values below method detection limit.
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3.3. Antibiotic residues in final effluents of wastewater treatment plants
located in different European countries and their impact on the aquatic
environment”
Taking advantage of the dataset of antibiotics measured in the ef-
fluent samples from 13 WWTPs, an environmental risk assessment
(ERA) for the different European countries was performed. For this
assessment, it was assumed that final effluents were discharged in
freshwater systems, a condition necessary to compare the potential
impact of the wastewater effluent of WWTPs located in different
European countries. The Environmental risk of antibiotics was assessed
by evaluation of the Risk Quotient (RQ), calculated as the ratio between
the Predicted Environmental Concentration (PEC) of each antibiotic in
the aquatic environment and the Predicted No Effect Concentration
(PNEC) (Section 2.4). Average values from the four sampling campaigns
(Table 1) were used to calculate PEC, whereas in the case of PNEC
values, the antibiotic-specific approach by Tell et al. (2019) was im-
plemented (see Section 2.4). PNEC is the concentration below which a
Fig. 2. Cumulative antibiotic concentrations (ng/L), grouped by chemical family, in the 4 sampling campaigns (Spring and Autumn, 2015, and Spring and Autumn,
2016) in each of the 13 WWTPs. Each band represents the sum of single antibiotics belonging to a chemical family; and each single antibiotic concentration is
calculated as the average concentration of the 3 consecutive sampling days. a, b, c and d indicate significant differences (p < 0.05) between sampling campaigns of
the same WWTP.
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chemical will likely have no adverse effect in an ecosystem. Among
other pharmaceuticals and emerging pollutants, antibiotics are of par-
ticular concern since they are explicitly designed to have an effect on
microorganisms and therefore, they are prone to impact microbial
communities in aquatic systems. A detrimental effect of antibiotics on
natural microbial communities could be the disappearance or inhibition
of some microbial groups involved in key ecosystem functions by bac-
tericidal and bacteriostatic effects (Grenni et al., 2018). However, low
concentrations of antibiotics, below the so-called “minimum inhibitory
concentration” (MIC), might also act as a selective force on some mi-
crobial populations, which can develop resistance (Andersson and
Hughes 2014). Having this in mind and with the aim of performing an
integrative environmental risk assessment we followed the re-
commendation by Tell et al. (2019) and took into account both, the
environmental PNECs (PNEC-ENVs) and the PNECs based on MIC
(PNEC-MICs): the lowest of the two values of PNEC-ENV or PNEC-MIC
for each antibiotic was chosen for the environmental risk assessment
(Table S7). Three categories according to the RQ value can be defined
using commonly used risk ranking criterion (Verlicchi et al., 2012; EC
TGD, 2003):
• RQ ≤ 0.1: Low environmental risk;
• 0.1 < RQ ≤ 1: Moderate environmental risk;
• RQ > 1: High environmental risk.
The RQ determined for 14 of the 17 antibiotics resulted in low en-
vironmental risk. The three exceptions were the cephalosporin cefa-
lexin, the fluoroquinolone ciprofloxacin and the macrolide azi-
thromycin, whose RQ exceeded the threshold of 0.1 (up to 0.14, 0.90
and 0.58 respectively) (Table 2). According to the results of this study,
these 3 antibiotics should be considered as posing a moderate en-
vironmental risk in water bodies in Portugal, Spain, Cyprus, and
Fig. 3. Antibiotic concentrations profile (ng/L) in the
13 WWTPs under study. Each column represents one
WWTP and each of the bars in the column represents
the average concentration from the 4 sampling
campaigns (March 2015, October 2015, March 2016
and September 2016) for all the antibiotics belonging
to a chemical family, except PT1 (average of March
2015, October 2015 and September 2016). PT3 (just
one sampling campaign in Spring 2016) is omitted.
Fig. 4. Comparison of (a) the total antibiotic concentration (excluding veterinary antibiotics enrofloxacin and orbifloxacin) measured in each country (ng/L). Values
for each year calculated as the average of antibiotic concentrations in early Spring and early Autumn sampling campaigns; and (b) the defined national daily dose
values (DDD) per 1000 inhabitants per day, for antibiotics consumed by the community (primary sector) (g). Values extracted from the “Annual Epidemiological
Report for 2016” from the European Centre for Disease Prevention and Control (ECDC) (https://ecdc.europa.eu/en/publications-data/antimicrobial-consumption-
annual-epidemiological-report-2016. Countries: PT, Portugal; ES, Spain; CYP, Cyprus; IL, Ireland; DE, Germany; FI, Finland; NO, Norway. * For Cyprus data on
consumption in hospital sector is also included. Specific information about the antibiotic types in each year and country is shown in Fig. S2.
S. Rodriguez-Mozaz, et al. Environment International 140 (2020) 105733
7
Germany. Portugal, Spain and Ireland were the countries with the
highest concentrations of antibiotics encountered in the WWTP effluent
samples (Fig. 3). The average concentration values for ciprofloxacin in
this study ranged between 38.4 in Finland (FI2) to 584.9 in Portugal
(PT2) (Table 1), whereas in previous studies levels reported were of
140 ng/L in USA (Renew and Huang, 2004), 199 ng/L in Greece
(Papageorgiou et al., 2016), 211 ng/L in Slovakia (Birošová et al.,
2014), 640 ng/L in Australia (Watkinson et al., 2007), or 700 ng/L in
Spain (Gracia-Lor et al., 2012). Also, similar values for azithromycin
(between 45.2 ng/L in CYP2 and 597.5 ng/L in PT2; table 1) were
found in other countries: 50 ng/L in Czech Republic (Golovko et al.,
2014), 277 ng/L in Germany (Rossmann et al., 2014), 504 ng/L in
Slovakia (Birošová et al., 2014). In the case of cefalexin, found up to
308 ng/L in Finland (FI2) (table 1) in this study, it has been detected in
China, 980 ng/L (Gulkowska et al., 2008), U.S.A. 2 330 ng/L
(Mohapatra et al., 2016) or Australia at 3 900 ng/L (Watkinson et al.,
2007). The relatively high concentrations determined for these 3
compounds in conjunction with the low dilution factors defined for
Portugal, Spain and Cyprus (61, 26 and 6, respectively) place these
countries in the top list of environmental risk due to antibiotic pollution
emitted by final effluents of urban WWTPs, among the countries stu-
died. The dilution factor in these countries may be relatively low
(Acuña et al., 2015) as in these areas streams can be dominated by
municipal and/or industrial effluent discharges, particularly in urba-
nized watersheds. In addition, Iberian rivers (Portugal and Spain) may
be highly influenced by water scarcity in drought periods (Pereira et al.,
2017). In the case of Cyprus, where rivers are inexistent, treated was-
tewater is reused for irrigation (agriculture and landscape), or it is in-
filtrated through shallow ponds reaching the aquifer (IMPEL, 2018).
Contrasting with Cyprus, where risk was aggravated by the low dilution
factor, rather by the high antibiotic load, in Ireland, the high dilution
factor of 230 compensated the high concentrations of antibiotics found
in the effluents of the WWTPs analysed. The low dilution factor defined
for Germany (32) together with some remarkable high concentrations
of antibiotics in the effluent samples from one WWTP, DE2, where only
CAS treatment was applied (Table S2), lead to relatively high RQ for
ciprofloxacin and azithromycin (0.12 and 0.45 respectively, Table 2). In
contrast, in the effluent samples from WWTP DE1, where ozone treat-
ment was applied as tertiary treatment, and low concentrations of an-
tibiotics were found, no risk for the environment was identified. Finally,
northern countries Norway and Finland, exhibited the highest dilution
factor (2453 and 1702 respectively) and also the lowest levels of anti-
biotics, resulting in low risk for the environment (RQs < 0.1).
This picture produced for water bodies (based on the average
concentration values of antibiotics in the effluent samples from
WWTPs) can mask some occasional critical situations regarding anti-
biotic pollution. Therefore, RQs were also calculated for the highest
concentration measured in all sampling campaigns in order to predict
worst-case scenarios (Table S8). Fig. 5 shows the PEC values in all
sampling campaigns for the antibiotics that showed the highest RQ
values, i.e. the fluoroquinolone ciprofloxacin and the macrolide azi-
thromycin. As shown in Fig. 5, in a single occasion PEC exceeded the
lowest PNEC (Table S7), a situation that corresponds to RQ ≥ 1. This
scenario was observed for azithromycin occurrence in the effluent
samples from the WWTP in Spain in the winter campaign of 2015.
RQ values determined in other studies, based on the measured en-
vironmental concentration (MEC) instead of the PEC values, revealed
low or moderate environmental risk for some trophic levels in different
countries. Surface water RQ values indicated a moderate risk of adverse
chronic effects (RQ > 0.1) for trimethoprim (out of 10 antibiotics
measured) in a river in Sweden (Sörengård et al., 2019), whereas sul-
famethoxazole and ofloxacin were reported to be the antibiotics with
the highest risk to the environment out of 13 antibiotics monitored in
surface water from China, with RQ values of 0.23 and 0.45, respectively
(Hu et al., 2018). RQ values higher than 1 have been reported in some
surface waters in China: up to 31.3 for sulfamethoxazole and 1.5 for
ofloxacin (Li et al., 2012) or in the surface water of a highly urbanized
area in Italy: up to 7.09 for clarithromycin and 11.33 for amoxicillin
(Riva et al., 2019). Most of these studies did not consider PNEC-MIC
values when assessing environmental risk but regular PNEC-ENV,
which were available from the literature or by in-silico calculations and
selected based on authors own criteria in each case and therefore,
comparison cannot be considered conclusive.
Ciprofloxacin and azithromycin, both highlighted in this study as
antibiotics of potential environmental concern, have also been included
in the last version of the surface water Watch List (WL) under the Water
Framework Directive (WFD) (Commission Implementing Decision,
2018). This Watch list proposes 15 substances that should be monitored
in water by the EU Member States. Besides ciprofloxacin and azi-
thromycin, the macrolides erythromycin and clarithromycin, and the
penicillin amoxicillin are also included in this list. The inclusion of 5
antibiotics among the 15 compounds in this list is consistent with the
latest “European One Health Action Plan against Antimicrobial Re-
sistance (AMR)”, which supports the use of the watch list to improve
knowledge of the occurrence and spread of antimicrobials in the en-
vironment (European Commission, 2017). Other organisms as the U.S.
Environmental Protection Agency (EPA), responsible for testing and
regulating chemicals in drinking water, does not regulate the presence
Table 2
Risk Quotients (RQs) in freshwater calculated for the average concentration (4 sampling campaigns) for the 17 antibiotics detected in the samples from the 13
WWTPs. RQ are calculated using Eqs. (1) and (2) (see Section 2.4). Environmental Risk: RQ≤ 0.1: Low; 0.1 < RQ≤ 1: Moderate; RQ > 1: High. Values in bold
correspond to RQ > 0.1, moderate or high risk. Portugal (PT), Spain (ES), Cyprus (CYP), Ireland (IL), Germany (DE), Finland (FI), Norway (NO).
Chemical groups PT1 PT2 PT3 ES1 CYP1 CYP2 IL1 IL2 DE1 DE2 FI1 FI2 NO1
Cephalosporins Cefalexin 0.01 0.01 0.00 0.03 0.14 0.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dihydrofolate reductase inhibitors Trimethoprim 0.00 0.00 0.01 0.01 0.03 0.02 0.00 0.00 0.00 0.01 0.00 0.00 0.00
Fluoroquinolones Ciprofloxacin 0.12 0.16 0.06 0.13 0.90 0.72 0.02 0.02 0.02 0.12 0.00 0.00 0.00
Enrofloxacin 0.00 0.00 0.00 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Ofloxacin 0.00 0.01 0.00 0.01 0.10 0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Orbifloxacin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Lincosamides Clindamycin 0.00 0.01 0.01 0.04 0.01 0.05 0.00 0.00 0.00 0.03 0.00 0.00 0.00
Macrolides Azithromycin 0.30 0.49 0.15 0.58 0.41 0.39 0.06 0.06 0.20 0.45 0.00 0.00 0.00
Clarithromycin 0.02 0.02 0.06 0.05 0.00 0.03 0.01 0.01 0.03 0.05 0.00 0.00 0.00
Nitroimidazole antibiotics Metronidazole 0.00 0.00 0.00 0.02 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Penicillins Ampicillin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Quinolones Nalidixic Acid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Oxolinic Acid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Pipemidic Acid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Sulfonamides Sulfamethoxazole 0.00 0.00 0.00 0.01 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Sulfapyridine 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tetracyclines Tetracycline 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
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of any antibiotic although the macrolide erythromycin is now included
on the “Drinking Water Contaminant Candidate List (CCL-4) (U.S. EPA,
2016), a list of c.a. 100 contaminants that are anticipated to occur in
public water systems. The inclusion of antibiotics in the lists of different
pre-regulation initiatives, is a recognition of the growing concern re-
lated to these compounds.
As it is currently not feasible to analyse all micropollutants, the
selection of a set of indicator compounds in regular water-monitoring
programs is recommended. In Section 3.1 the 17 antibiotics detected at
least once in the sampling campaigns (among a group of 53 substances
screened) were suggested as potential markers for antibiotic pollution,
so that “smart monitoring” can be attained by analysing this reduced
number of compounds. However, the assignment of RQs to these 17
selected contaminants detected in the effluent samples from WWTPs
support a further reduction of possible indicator compounds. Based on
risk assessment criteria, three compounds, ciprofloxacin, azithromycin,
and cefalexin, are suggested as indicator candidates. These antibiotics
had the highest RQs in a number of countries (Table 2). The use of the
broader panel (17 compounds) or the short-list (3 compounds) can both
be options to consider depending on the goals of the monitoring pro-
gram.
Some final considerations should be kept in mind concerning the
environmental risk assessment. Firstly, antibiotics enter and are present
in the aquatic environment as a mixture, either of different compounds
belonging to the same class of antibiotics, acting by similar mechan-
isms, or of different therapeutic groups, which may have synergistic or
antagonistic effects, sometimes with the possibility of exerting ex-
acerbated effects in relation to the single compounds (Backhaus and
Faust 2012). In addition, it is known that body- or environment-driven
transformation of parent compounds cause metabolites (or by-products)
to occur in the environment. These antibiotic by-products very often
retain the antibiotic activity to a certain degree and can all be found at
high concentrations in the final wastewater effluent (Fatta-Kassinos
et al., 2011). The monitoring of these compounds, based on chemical
analytical methods or bioassays is, therefore, necessary to improve the
accuracy of risk assessment due to antibiotic pollution in water bodies.
4. Conclusions
This comprehensive monitoring study of a broad set of antibiotics in
several countries is the first such study performed at a European level.
The study has primarily allowed us to define the current water quality
status of the urban wastewater effluents in Europe. Within the 53 an-
tibiotics analysed in the sampling campaigns, 17 were detected in
treated wastewater effluents. Ciprofloxacin, azithromycin, and cefa-
lexin were selected as markers of antibiotic pollution and are suggested
to be used for widespread temporal and geographical characterization
of environmental water or WWTP effluents. In addition, a north-to-
south geographical gradation was observed in terms of antibiotic
amounts released in the environment. Compounds with the highest
loads in all countries were macrolides and fluoroquinolones. Although
the WWTPs examined in this study were complying with EU legislation,
antibiotic residues of at least 7–12 distinct compounds, each at con-
centrations ranging from 3 to 598 of ng/L, were observed to be con-
tinuously discharged in freshwater and marine ecosystems, impacting
the environment and possibly contributing to antibiotic resistance
evolution. Although the detected levels of antibiotics released in the
environment were predicted to exhibit a moderate impact on the en-
vironment in general, antibiotics such as azithromycin and cipro-
floxacin can occasionally pose a risk to the environment and antibiotic
resistance development. The situation regarding environmental anti-
biotic pollution can be further worsened in the future in the frame of
global change, with population growth, intensified agricultural and
industrial activity, together with water scarcity in vulnerable areas such
as southern European countries. Our study provides a framework for
predicting the likelihood for selecting antibiotic resistant bacteria in
water bodies containing antibiotics released from WWTPs.
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